Skip to content
HeyJared

ACR Open Rheumatol

Reporter · US

Indexed articles, last 90 days
3
Latest publication
Aug 28, 2026
Outlet visibility, for Medscape
Top 50K sites
Earliest in this view
Aug 3, 2026
The latest indexed work is over 30 days old. There may be a gap in what we hold.

Latest articles

  1. Article · Aug 28, 2026 · ACR Open Rheumatol. 2026;8(8):e90106.

    Does Vitamin B3 Benefit Patients With Raynaud Phenomenon? (opens the original)

    Excerpt · Positive tone · English

    Read excerpt

    Oral vitamin B3 (nicotinamide) at 500 mg twice daily for 14 days improved nailfold videocapillaroscopy (NVC) patterns in around 45% of participants with primary or scleroderma-related Raynaud phenomenon (RP), with increased normal capillaries and reduced abnormal features. Participants with primary RP experienced improvements in RP-related quality of life. "[O]ral nicotinamide 500 mg twice daily for 14 days was largely safe and well tolerated in both primary and scleroderma-related RP groups," t

  2. Article · Aug 4, 2026 · ACR Open Rheumatol. 2026-08-01;8(8):e90119.

    Biosimilar Rituximab Matches Originator in ANCA Vasculitis (opens the original)

    Excerpt · English

    Read excerpt

    Rituximab biosimilars achieved remission in a notable proportion of patients with antineutrophil cytoplasm antibody (ANCA)-associated vasculitis (AAV) by 6 months, with no significant differences compared to the originator. No relapses occurred in patients who switched from originator to biosimilar maintenance therapy. "The present study provides unique real-world evidence of the rituximab originator compared to the biosimilar in AAV, comprehensively evaluating vasculitis control, damage, SAEs i

  3. Article · Aug 3, 2026 · ACR Open Rheumatol. 2026-08-01;8(8):e90047.

    Sjögren's Disease Tied to Increased Infection Risk (opens the original)

    Excerpt · English

    Read excerpt

    Patients with Sjögren's disease were diagnosed with infectious diseases more frequently than matched control individuals with sicca symptoms or other autoimmune diseases, especially younger patients and those positive for anti-Sjögren's-syndrome-related antigen A (SSA) autoantibodies. "[The] results support the need for improved infection surveillance and preventive strategies, such as vaccination and early antimicrobial management, particularly in high-risk subgroups," the authors of the study

Publishing over time

Last 90 days. Choose a month to open its work.

Recurring subjects

Named in the text we hold. One piece can cover several.

Audience

Top 50K sites

For Medscape, the outlet · Measured Aug 1, 2026

Website popularity band, not a count of readers or article views.

About this data

Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.

Identity or attribution wrong? Suggest a correction.

See coverage about ACR Open Rheumatol